Prdx3 has been reported to promote pyroptosis in benign prostatic hyperplasia (BPH) [35] and also act as a suppressor of pyroptosis by inhibiting NLRP3 inflammasome activation [36]. Here, NLRP3 is linked to benign prostatic hyperplasia.